Bio-Rad Labs (BIO) Misses Q3 EPS by 46c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $282.44 -0.78%
EPS Growth %: -30.7%
Financial Fact:
Net income per share basic attributable to Bio-Rad: 0.61
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -30.7%
Financial Fact:
Net income per share basic attributable to Bio-Rad: 0.61
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q3 EPS of $0.40, $0.46 worse than the analyst estimate of $0.86. Revenue for the quarter came in at $530.6 million versus the consensus estimate of $525.4 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Pfizer reafffirms 2026 guidance after CFO transition announcement
- FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
